<DOC>
	<DOC>NCT02634788</DOC>
	<brief_summary>The primary objective of this trial is to evaluate analgesic efficacy of Buprenorphine Sublingual Spray compared with placebo in subjects with postoperative pain after bunionectomy.</brief_summary>
	<brief_title>Study of Buprenorphine Sublingual Spray for the Treatment of Moderate to Severe Pain</brief_title>
	<detailed_description />
	<mesh_term>Buprenorphine</mesh_term>
	<criteria>Meets protocolspecified criteria for qualification and contraception Willing and able to remain confined in the study unit for the entire duration of each treatment period and comply with restrictions related food, drink and medications Voluntarily consents to participate and provides written informed consent prior to any protocolspecific procedures History or current use of overthecounter medications, dietary supplements, or drugs (including nicotine and alcohol) outside protocolspecified parameters Signs, symptoms or history of any condition that, per protocol or in the opinion of the investigator, might compromise: 1. the safety or wellbeing of the participant or study staff; 2. the safety or wellbeing of the participant's offspring (such as through pregnancy or breastfeeding); 3. the analysis of results</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Post-Surgical Pain</keyword>
	<keyword>Bunionectomy</keyword>
</DOC>